Ensuring effective access to essential medicines in Thai UHC

Meeting Organizer

Health Systems Research Institute (HSRI), Thailand

Ministry of Public health, Food and Drug Administration, Pharmacy Council, Thai Industrial Pharmacist Association and Thai Drug Watch

Contact Person : NoppakunThammatacharee,

29 January 2020
09:00 - 17:30 hrs.
Venue : World Ballroom A, FL. 23

Open to All Participants


Health expenditure on medicines in Thailand has been increasing substantially. It is estimated that medicine costs account for more than 40% of total health expenditure. This is due to the change in population structure, complicated health conditions and expensive technology. Additionally, arrangements within the medicine system can affect Thailand’s ability to control medicine costs and maintain good health for the Thai population. Such arrangements include management of the overall medicine supply chain, inputs such as human resources, financing provided to the medicine system and, most importantly, policy and regulations on pharmaceutical products at national and international levels. Access to affordable essential medicines on a sustainable basis is covered in Sustainable Development Goal Target 3.8 to achieve universal health coverage (UHC). Access to medicines can be achieved in a number of ways such as transparent pricing and procurement, increased regulatory capacity, streamlined administrative procedures, support to local manufacturing processes and improvement in rational use of medicines.


1) Share and discuss current situation about key activities, outputs/outcomes, and progress on medicine systems by public health practitioners, academicians, policy makers, and other interest groups 2) Provide evidence for policies, regulations and systems for the medicine system in Thailand 3) Address common and major gaps to further identify areas in need of greater attention 4) Advocate effective responses to meeting the challenges of the Thai medicine system